Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,179
archived clinical trials in
Anxiety

Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria
Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study
Status: Enrolling
Updated:  12/8/2015
Vision Specialists of Birmingham
mi
from
Birmingham, MI
Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria
Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study
Status: Enrolling
Updated: 12/8/2015
Vision Specialists of Birmingham
mi
from
Birmingham, MI
Click here to add this to my saved trials
Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth
RCT of an Animal-Assisted Intervention With Adjudicated Youth
Status: Enrolling
Updated:  12/8/2015
Macomb County Juvenile Justice Center
mi
from
Mt. Clemens, MI
Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth
RCT of an Animal-Assisted Intervention With Adjudicated Youth
Status: Enrolling
Updated: 12/8/2015
Macomb County Juvenile Justice Center
mi
from
Mt. Clemens, MI
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Comprehensive Clinical Development Inc.
mi
from
Cerritos, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Comprehensive Clinical Development Inc.
mi
from
Cerritos, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Pharmacology Research Institute
mi
from
Encino, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Sun Valley Research Center
mi
from
Imperial, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Sun Valley Research Center
mi
from
Imperial, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Excell Research, Inc.
mi
from
Oceanside, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
NRC Research Institute
mi
from
Orange, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
California Neuorpsychopharmacology Clinical Research Institute, LLC (CNRI-San Diego, LLC)
mi
from
San Diego, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
California Neuorpsychopharmacology Clinical Research Institute, LLC (CNRI-San Diego, LLC)
mi
from
San Diego, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
The Hartford Hospital
mi
from
Hartford, CT
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Avail Clinical Research
mi
from
DeLand, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Gulfcoast Clinical Center
mi
from
Fort Meyers, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Gulfcoast Clinical Center
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Sarkis Clinical Trials
mi
from
Gainesville, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Berma Research Group
mi
from
Hialeah, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Berma Research Group
mi
from
Hialeah, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Sarkis Clinical Trials
mi
from
Lake City, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Sarkis Clinical Trials
mi
from
Lake City, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Stedman Clinical Trials
mi
from
Tampa, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Atlanta Center for Medical Research
mi
from
Atlanta, GA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Northwest Behavioral Research Center
mi
from
Roswell, GA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Northwest Behavioral Research Center
mi
from
Roswell, GA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Great Lakes Clinical Trials
mi
from
Chicago, IL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Great Lakes Clinical Trials
mi
from
Chicago, IL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Phoenix Medica Research, Inc
mi
from
Prairie Village, KA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Phoenix Medica Research, Inc
mi
from
Prairie Village, KA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Pharmasite Research
mi
from
Baltimore, MD
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Pharmasite Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
ActivMed Practices & Research
mi
from
Methuen, MA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
ActivMed Practices & Research
mi
from
Methuen, MA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
BCCR Trials
mi
from
Natick, MA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
BCCR Trials
mi
from
Natick, MA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Premier Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Premier Psychiatric Research Institute, LLC
mi
from
Lincoln, NE
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Bio Behavioral Health
mi
from
Toms River, NJ
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Bio Behavioral Health
mi
from
Toms River, NJ
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Comprehensive Clinical Development
mi
from
Jamaica, NY
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Comprehensive Clinical Development
mi
from
Jamaica, NY
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Bioscience Research, Llc
mi
from
Mount Kisco, NY
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Fieve Clinical Research
mi
from
New York, NY
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Fieve Clinical Research
mi
from
New York, NY
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
CTI Clinical Research Center
mi
from
Cincinnati, OH
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
CTI Clinical Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Patient Priority Clinical sites, LLC
mi
from
Cincinnati, OH
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Patient Priority Clinical sites, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Cutting Edge Research Group
mi
from
Oklahoma City, OK
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Suburban Research Associates
mi
from
Media, PA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Suburban Research Associates
mi
from
Media, PA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
FutureSearch Trials of Dallas
mi
from
Dallas, TX
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
InSite Clinical Research LLC
mi
from
DeSoto, TX
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Northwest Clinical Research Center
mi
from
Bellevue, WA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Pacific Clinical Research Medical Group
mi
from
Upland, CA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Pacific Clinical Research Medical Group
mi
from
Upland, CA
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Institute of Living
mi
from
Hartford, CT
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Institute of Living
mi
from
Hartford, CT
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Medical Research Group of Central Florida
mi
from
Orange City, FL
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Medical Research Group of Central Florida
mi
from
Orange City, FL
Click here to add this to my saved trials
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated:  12/11/2015
Beacon Clinical Research, LLC
mi
from
Brockton, MA
POC Study in Partially Responsive Generalized Anxiety Disorder
An 8-week, Randomized, Phase 2, Double-blind, Sequential Parallel-group Comparison Study Of Two Dose Levels Of Pf 06372865 Compared To Placebo As An Adjunctive Treatment In Outpatients With Inadequate Response To Standard Of Care For Generalized Anxiety Disorder
Status: Enrolling
Updated: 12/11/2015
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Click here to add this to my saved trials